Gaudium IVF and Women Health Limited has announced the launch of its Initial Public Offer (IPO) of equity shares, scheduled to open for public subscription on February 20, 2026, and close on February 24, 2026. The anchor investor bidding will be conducted on February 18, 2026.
The IPO is priced in a band of ₹75 to ₹79 per equity share, each having a face value of ₹5. Investors can apply for a minimum of 189 shares and in multiples thereafter.
The offer comprises a fresh issue of up to 1,13,92,500 equity shares along with an offer for sale of up to 94,93,700 shares by promoter Dr. Manika Khanna. The company plans to utilize the net proceeds for setting up new IVF centres, repayment or prepayment of certain loans, and general corporate purposes.
The equity shares are proposed to be listed on the main boards of BSE Limited and National Stock Exchange of India Limited, with NSE as the designated stock exchange.
Sarthi Capital Advisors Private Limited is the sole Book Running Lead Manager for the issue.
